Rates of cannabis use disorder in adolescents have increased in states that have legalized recreational use, according to a new observational study.
The authors of the new study claim that CBD’s anti-seizure effects could be attributed to a separate drug, which was also given to many of patients involved in clinical trials.
The Association for the Cannabinoid Industry has been launched to bring together businesses and industry experts committed to “fostering a legally compliant, socially responsible and innovative CBD industry, which puts customers’ safety first.”
In a bid to create the largest body of evidence on medical cannabis in Europe, up to 20,000 patients in the UK will be enrolled in a two-year-long medical cannabis project.
The poll followed a Royal Society of Medicine seminar on medical cannabis, which was attended by 200 medical professionals.
After vaping high CBD cannabis that contained 0.39 percent THC, one third of a new study’s participants tested positive on a standard urine test similar to those used for employment-related or criminal justice-related drug testing programs.
With the health and safety spotlight now firmly on vaping, Dr Graham Wood says that regulators shouldn’t miss this chance to properly assess vaping’s potential harms.